Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16314699rdf:typepubmed:Citationlld:pubmed
pubmed-article:16314699lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:16314699lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:16314699lifeskim:mentionsumls-concept:C1948041lld:lifeskim
pubmed-article:16314699lifeskim:mentionsumls-concept:C0205234lld:lifeskim
pubmed-article:16314699lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:16314699lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:16314699pubmed:issue1lld:pubmed
pubmed-article:16314699pubmed:dateCreated2005-11-29lld:pubmed
pubmed-article:16314699pubmed:abstractTextThe aim of this article is to provide an overview of MRI features of primary and secondary liver lesions after intervention. Emphasis is given to T2- and T1-weighted pre and post intravenous gadolinium chelates appearance of successfully treated lesions and, from residual/recurrent tumors after therapy. In addition, complications after procedures are briefly cited. Liver resection, radiation therapy, systemic chemotherapy, transcatheter arterial chemoembolization, ablative therapies and liver transplantation are the methods discussed in this review. Among these methods, special attention is given to MRI findings after ablative therapies since radiofrequency ablation is commonly performed in our institution.lld:pubmed
pubmed-article:16314699pubmed:languageenglld:pubmed
pubmed-article:16314699pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16314699pubmed:citationSubsetIMlld:pubmed
pubmed-article:16314699pubmed:statusMEDLINElld:pubmed
pubmed-article:16314699pubmed:monthFeblld:pubmed
pubmed-article:16314699pubmed:issn0899-3459lld:pubmed
pubmed-article:16314699pubmed:authorpubmed-author:SemelkaRichar...lld:pubmed
pubmed-article:16314699pubmed:authorpubmed-author:BragaLarissaLlld:pubmed
pubmed-article:16314699pubmed:issnTypePrintlld:pubmed
pubmed-article:16314699pubmed:volume16lld:pubmed
pubmed-article:16314699pubmed:ownerNLMlld:pubmed
pubmed-article:16314699pubmed:authorsCompleteYlld:pubmed
pubmed-article:16314699pubmed:pagination99-106lld:pubmed
pubmed-article:16314699pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:meshHeadingpubmed-meshheading:16314699...lld:pubmed
pubmed-article:16314699pubmed:year2005lld:pubmed
pubmed-article:16314699pubmed:articleTitleMagnetic resonance imaging features of focal liver lesions after intervention.lld:pubmed
pubmed-article:16314699pubmed:affiliationSchool of Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, NC 27599-7510, USA.lld:pubmed
pubmed-article:16314699pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16314699pubmed:publicationTypeReviewlld:pubmed